Budd-Chiari syndrome and its associated hepatocellular carcinoma: Clinical risk factors and potential immunotherapeutic benefit analysis

BACKGROUND: Hepatocellular carcinoma (HCC) is a well-described complication of Budd-Chiari syndrome (BCS). However, the risk factors of BCS in developing HCC and clinical characteristics and imaging features of BCS-associated HCC is still to be determined. METHODS: Data from 113 consecutive patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Kang-Shuai, Guo, Sen, Chen, Yu-Xin, Zhang, Zong-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774021/
https://www.ncbi.nlm.nih.gov/pubmed/36568193
http://dx.doi.org/10.3389/fonc.2022.1075685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774021/
https://www.ncbi.nlm.nih.gov/pubmed/36568193
http://dx.doi.org/10.3389/fonc.2022.1075685

Ejemplares similares